ASHLEIGH CHRISTOPHER: Open Payments
NPI 1003697921 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,188 in 37 payments from 13 companies in 2025. Trend: 2023 $146 · 2024 $1,588 · 2025 $1,188
Food & beverage: $1,045Education: $143
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $564 |
| ABBVIE INC. | 9 | $199 |
| GENZYME CORPORATION | 4 | $154 |
| Incyte Corporation | 1 | $89 |
| Galderma Laboratories, L.P. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| KYOWA KIRIN, INC. | 1 | $20 |
| LEO Pharma Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Almirall LLC | 1 | $15 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, Opzelura, RINVOQ, NEMLUVIO, POTELIGEO, ADBRY.
Industry payments across FL — which companies pay providers there.
